Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.
Registration is now open until January 15, 2027, at 5 p.m. ET, replacing the notice that registration would open November 2, 2026. A direct registration link has also been added.
Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
Real-World Evidence Innovation Challenge supports individuals, teams, and entities validating clinical data analytic methods to establish reliable, reproducible performance across health systems.
FDA funds research on complex generics to expand access to safe, effective generic medicines and reduce drug shortages through a more competitive, multi-sourced U.S. market.
FDA grant to fund a center researching complex generics, fostering collaboration between the FDA, industry, academia, and the public to improve access to generic drugs.
NIH Complement Animal Research in Experimentation NAMs Reduction to Practice Challenge supports teams developing human-based testing platforms to improve predictions of human responses and complement animal models.